![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Trellus Health Plc | LSE:TRLS | London | Ordinary Share | GB00BNNFM402 | ORD GBP0.0006 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.21 | 13.55% | 1.76 | 1.60 | 1.80 | 1.70 | 1.55 | 1.55 | 2,888,715 | 16:40:34 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Offices Of Medical Doctors | 19k | -6.34M | -0.0392 | -0.43 | 2.5M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/5/2022 10:03 | Analyst comments wrt today's prelims. www.linkedin.com/pos | ![]() brummy_git | |
10/5/2022 08:53 | Interesting evolution/change in strategy, which should be a more scalable, robust and sustainable offering, with managements expectation to deliver a significant number of additional patients in Q4 2022. From my perspective, whilst the evolution in strategy is welcome (and needed), it will be interesting to see how differentiated the Trellus offering is, of which the delivery of a significant number of patients across B2B and DCT, including those resulting from the advanced discussions with numerous large pharmaceutical companies and patient advocacy groups, will likely prove to be an important indicator for what lies ahead, especially as this will be for only IBD. Furthermore, expanding into other chronic conditions that can benefit from a 'disease-agnostic' approach to assessing and building resilience and thereby improving mental health, if proven 'commercially' to demonstrate meaningful improvements in patient outcomes whilst generating significant cost savings for healthcare payers, along with the significant unmet need, could result in very high rates of growth. Therefore, against a challenging backdrop, the next 6 months could be pivotal (one way or another). | ![]() wan | |
31/3/2022 13:47 | Yes, I will probably look for an alternative to ii, they aren’t easy to deal with! Although I’m struggling to see a better alternative! | ![]() adobbing | |
31/3/2022 13:02 | adobbing - thanks for the update. What a shambles! They are still referring to the 'A' ordinary shares that I pointed out to them 4 weeks ago have not existed since 28th May last year. | ![]() sharw | |
11/3/2022 18:17 | adobbing - I have now had a reply saying that the line in my portfolio for Trellus is a dummy line to reflect those shares which I am due to receive in the future. This makes their statement to you all the more bizarre - if it is a dummy line there is nothing to be moved elsewhere! | ![]() sharw | |
04/3/2022 20:57 | @sharw Thanks for the update. I’d almost forgotten about them, until I got the note. My understanding was that they would convert at some point in time, to tradable shares. I did buy some Trellus and my original intention was to hold until the two holdings merged, then sell. But with the fall in price I liquidated those a while back. I’ll follow up with them next week! | ![]() adobbing | |
04/3/2022 20:30 | adobbing - just seen your note re ii action needed. I find this quite extraordinary - these were issued over a year ago - why has ii only just taken action - I had a share which delisted and my memory says the rule then was that you had 30 days to transfer out of an ISA. Furthermore there have been no other comments here on other brokers doing the same. I think you should challenge this on the grounds that they are talking about Trellus Health A ordinary shares and these no longer exist, Check this - As I read it the A ordinary shares converted to ordinary shares on 28th May last year (on AIM admission) and those shares certainly are ISA admissable unless there is some HMRC clause that says not because you are prevented from trading them until 28th May this year. I have now told ii about this wrong description (they are in my trading a/c so I did not get the message you did) saying that if they are correctly described it will show the market value, not zero. | ![]() sharw | |
04/3/2022 15:47 | Justin Waite & I of Vox Markets discussed Trellus health here today (starts 47:30). www.voxmarkets.co.uk | ![]() brummy_git | |
28/2/2022 11:07 | Can't be anything other than very good news. Sales mean revenue even if it will probably be slow to build as it is on a case by case flow. The more important point is that TRLS has a commercial service ready to go and it will now be able to prove the concept in real live paying patients. | ![]() mikemine1 | |
28/2/2022 08:09 | New BTC healthcare service launched by Trellus Health. A pioneer providing a ‘1st-of-its-ki All the news & commentary here. www.linkedin.com/pos | ![]() brummy_git | |
28/2/2022 08:01 | Added some this am. | albert arthur | |
23/2/2022 15:31 | Just got a note on my ii account relating to the shares issued by EKF; Stock TRELLUS HEALTH A ORDINARY Event Type Confirmation Description ISA-Ineligible Holding Name of stock: Trellus Health Date by which you need to transfer, or request withdrawal: 9th March 2022 Your Trellus Health A ordinary shares are not deemed to be ISA-eligible under HMRC rules. You therefore have until 9th March 2022 to request that we move them from your ISA account into your ii Trading account if you have one. In order to move the shares please select “Cash & Transfers” from your account page, then “Transfer in”, and “Account to Account Transfer”. A new page will open where you will be able to instruct us to transfer the shares. Alternatively, you may wish to withdraw the shares into certificated form which will be registered in your own name and posted to you; please contact us by phone if that is the case. If you take no action before 9th March 2022, we will endeavour to remove the shares from your ISA. This may involve transferring the shares into your Trading account if you have one, opening a Trading account on your behalf and transferring the shares into that account, or withdrawing the shares and re-registering them into your own name. Which of these options applies will be determined by us at the time in our capacity as the ISA Manager. Withdrawals are not possible for Junior ISA Accounts so if you hold these shares in a Junior ISA they will remain on the account. Anybody had similar and if so what are you doing? | ![]() adobbing | |
21/2/2022 11:30 | All the positive talk has the share at 33p as opposed to the flotation price last year of .40p | ![]() hybrasil | |
03/2/2022 05:24 | Paul Jourdan of Amati Global talks positively briefly about Trellus Health here (starts 44:00) www.youtube.com/watc | ![]() brummy_git | |
22/1/2022 04:00 | TRLS (starts 20:50) discussed by Paul Hill & Justin Waite of Vox markets here www.youtube.com/watc | ![]() brummy_git | |
17/1/2022 18:54 | Those improvement figures are nothing short of astounding and any clinical trial with those numbers would be deemed a significant success. The report may not have set the Market alight but the revenues that should follow will, as clinicians take up what TRLS is offering. | ![]() mikemine1 | |
17/1/2022 09:30 | More positive clinical data supporting the use of Trellus Health's proprietary chronic disease management platform. All the news & comment here. www.linkedin.com/pos | ![]() brummy_git | |
05/1/2022 13:43 | Thanks Aspringo. Mine are sat in an ii account, like yours they show £0 value. Not exactly a large value, but I like to today these things up! | ![]() adobbing | |
05/1/2022 12:31 | adobbing, I also wondered, as they are sitting as an entitlement with zero value in my barclays account.I know wan is knowledgeable on these as he did answer once before.Unfortunately this past year has been a year of upset, and I can't remember exactly what he said.I'm sure barclays know what they're doing, haha.All the best for a better year. | ![]() aspringo | |
04/1/2022 12:51 | So I’m guessing that the date the “Lock up” would end, would be on or around 28/5/22 as that will be a year since trading of TRLS commenced? | ![]() adobbing | |
23/12/2021 10:32 | Question around In Specie shares from EKF. Below is from the Corporate action on EKF dated 24/12/20. When do these become available, is it tomorrow or longer? Terms: 1 A share in Trellus Health Limited for every 16.25 EKF Diagnostics Holdings plc shares held Ex-entitlement date: 16th December 2020 EKF Diagnostics Holdings plc has announced a distribution in specie, whereby holders will be issued with 1 A ordinary share in Trellus Health Limited for every 16.25 existing shares in EKF Diagnostics Holdings plc held. The ex-entitlement date is 16th December 2020. EKF Shareholders will become the beneficial owners of their respective Dividend Shares upon completion of the transfer of the Dividend Shares to Broadway Nominees Limited, at which time an `omnibus` share certificate in respect of the Dividend Shares will be issued and held by Broadway, to be held on trust by it on behalf of the Relevant EKF Shareholders for a period of 365 days following admission to trading on AIM (or another recognised stock exchange) of the issued share capital of Trellus; or if the issued share capital of Trellus is not admitted to trading on AIM (or another recognised stock exchange) within two years of the date that the Dividend is settled, two years from the date that the Dividend is settled. During the Lock-up Period, Relevant EKF Shareholders will not be permitted to transfer the legal or beneficial ownership of their Dividend Shares. The A Shares will, on the earlier of the admission to trading of Trellus on AIM (or another recognised stock exchange) and two years from the date that the Dividend is settled, automatically convert into ordinary shares in Trellus on the basis of one Ordinary Share for each A Share held. If Trellus is admitted to trading on AIM (or another recognised stock exchange), the Lock-up Period will continue to apply to the converted Ordinary Shares. All converted Ordinary Shares will rank equally in all respects with all other Ordinary Shares including in respect of voting and dividend rights. The legal title to the Dividend Shares will be held by Broadway as trustee, during the Lock-Up Period. If the A Shares are converted into Ordinary Shares during the Lock-up Period, Broadway will request that Trellus` registrar seeks the voting instructions of the Relevant EKF Shareholders in relation to any shareholder resolution of Trellus and will vote those Dividend Shares in accordance with such instructions as it receives. | ![]() adobbing | |
22/12/2021 11:18 | Christopher Mills talks positively about Trellus Health (55:50) here. www.linkedin.com/fee www.youtube.com/watc | ![]() brummy_git | |
19/12/2021 03:07 | A good podcast. In line with lots of companies, covid has hindered progress from TRLS's stated path but things are still on track. Just a bit late. I don't think it will materially affect the longer term ambition of commercialisation. Interest is still strong and, as far as I can see, competition is virtually non-existent. IMHO, the reaction to the reported delay is well over done and the price is very attractive for a medium to long term investment. | ![]() mikemine1 | |
15/12/2021 09:57 | Terrific comments here wrt yesterday's trading update from CEO Monique Fayad of Trellus Health www.voxmarkets.co.uk | ![]() brummy_git |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions